WallStreetZenWallStreetZen

NASDAQ: KLRS
Kalaris Therapeutics Inc Stock Ownership - Who owns Kalaris Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kalaris Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brett R. HagenChief Accounting Officer2025-03-26907$8.97
$8.13kSell
Edward MillerGeneral Counsel2025-02-21106$10.08
$1.07kSell
Vikas SinhaOfficer Title President Chief Financial Officer and Chief Executive Officer2025-02-21303$10.08
$3.05kSell
Brett R. HagenChief Accounting Officer2025-02-2196$10.08
$967.30Sell
Brett R. HagenChief Accounting Officer2025-01-2332$9.45
$302.53Sell
Vikas SinhaOfficer Title President Chief Financial Officer and Chief Executive Officer2025-01-23116$9.45
$1.10kSell
Edward MillerGeneral Counsel2025-01-235$9.94
$49.70Sell
Edward MillerGeneral Counsel2025-01-2347$9.45
$444.34Sell
Vikas SinhaOfficer Title President Chief Financial Officer and Chief Executive Officer2025-01-2313$9.94
$129.22Sell
Brett R. HagenChief Accounting Officer2025-01-234$9.94
$39.76Sell

1 of 6

KLRS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KLRS insiders and whales buy or sell their stock.

KLRS Shareholders

What type of owners hold Kalaris Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morana Jovanembiricos1,576.38%79,502,507$268.72MInsider
David Hallal1,382.05%69,701,844$235.59MInsider
Vikas Sinha676.61%34,123,650$115.34MInsider
Ansbert Gadicke597.34%30,125,933$101.83MInsider
Elevatebio LLC330.63%16,674,766$56.36MInsider
Gilead Sciences Inc329.85%16,635,286$56.23MInsider
Gilead Sciences Inc329.85%16,635,286$56.23MInstitution
Samsara Biocapital GP LLC226.99%11,448,081$38.69MInsider
Octagon Capital Advisors LP222.37%11,215,000$37.91MInstitution
F2 Mg Ltd194.87%9,828,091$33.22MInsider

1 of 3

KLRS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KLRS14.79%85.21%Net SellingNet Selling
IPA5.81%0.00%
GLYC30.15%69.85%Net Selling
LPTX35.95%64.05%Net SellingNet Selling
HOOK16.67%83.33%
View Top Biotech Stocks

Kalaris Therapeutics Stock Ownership FAQ

Who owns Kalaris Therapeutics?

Kalaris Therapeutics (NASDAQ: KLRS) is owned by 983.72% institutional shareholders, 5,668.70% Kalaris Therapeutics insiders, and 0.00% retail investors. Morana Jovanembiricos is the largest individual Kalaris Therapeutics shareholder, owning 79.50M shares representing 1,576.38% of the company. Morana Jovanembiricos's Kalaris Therapeutics shares are currently valued at $258.38M.

If you're new to stock investing, here's how to buy Kalaris Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.